(Q44188879)

30 November 2017

title

Novel human histamine H(3) receptor antagonists (English)

1 reference

30 November 2017

Chandra Shah

1

1 reference

30 November 2017

Laura McAtee

2

1 reference

30 November 2017

J Guy Breitenbucher

3

1 reference

30 November 2017

Dale Rudolph

4

1 reference

30 November 2017

Xiaobing Li

5

1 reference

30 November 2017

Timothy W Lovenberg

6

1 reference

30 November 2017

Curt Mazur

7

1 reference

30 November 2017

Sandy J Wilson

8

1 reference

30 November 2017

Nicholas I Carruthers

9

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

30 November 2017

volume

12

1 reference

30 November 2017

issue

22

1 reference

30 November 2017

page(s)

3309-3312

1 reference

The physiological action of beta-iminazolylethylamine

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Further observations on the action of beta-iminazolylethylamine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Definition and antagonism of histamine H 2 -receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Discovery of a novel member of the histamine receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Cloning, expression, and pharmacological characterization of a novel human histamine receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Cloning and functional expression of the human histamine H3 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Effects of histamine H3-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

[3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Intermediate affinity and potency of clozapine and low affinity of other neuroleptics and of antidepressants at H3 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Non-imidazole histamine H3 ligands. Part I. Synthesis of 2-(1-piperazinyl)- and 2-(hexahydro-1H-1,4-diazepin-1-yl)benzothiazole derivatives as H3-antagonists with H1 blocking activities

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H(3) receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Synthesis of potent non-imidazole histamine H3-receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Synthesis of (aryloxy)alkylamines. 2. Novel imidazo-fused heterocycles with calcium channel blocking and local anesthetic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900738-2

7 January 2021

10.1016/S0960-894X(02)00738-2

Identifiers

DOI

1 reference

30 November 2017

1 reference